A carregar...
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial
BACKGROUND: No therapies have been proven to persistently improve the outcome of HTLV-I-associated myelopathy. Clinical benefit has been reported with zidovudine and with lamivudine in observational studies. We therefore conducted a randomised, double blind, placebo controlled study of six months co...
Na minha lista:
Main Authors: | , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2006
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1590049/ https://ncbi.nlm.nih.gov/pubmed/16984654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4690-3-63 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|